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to define margins to account for these residual uncertainties. 
By shortening treatment time e.g. by the use of VMAT, we 
expect the intra-fraction cervix-uterus motion to decrease. 
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Purpose/Objective: Treatment-related toxicity for non-small 
cell lung cancer (NSCLC) patients can potentially be reduced 
by treating in deep inspiration breath hold (DIBH) due to 
increased lung volume. We investigated the reproducibility of 
tumour and lymph node position throughout a course of 
image guided radiotherapy (IGRT). 
Materials and Methods: 17 patients were included 
prospectively. An optical marker based system with visual 
guidance was used for respiratory monitoring, enabling 
comfortable voluntary DIBHs. During a coaching session a 
gating window of 2-3 mm was adjusted individually to each 
patient's performance. 
Besides imaging for radiotherapy (RT) planning, all patients 
had three additional imaging sessions at treatment fractions 
2, 16 and 31. Each session included three consecutive DIBH 
CTs and one DIBH CBCT, requiring three additional DIBHs. All 
patients were treated in free breathing. 
The reproducibility of DIBH was evaluated as intra- and inter-
fractional variations in DIBH lung volume, intra-fractional 
uncertainty in tumour position and intra-fractional 
differential motion between the primary tumour and the 
mediastinal lymph nodes (using carina as an image 
registration surrogate). When evaluating intra-fractional 
uncertainty, the second and third daily DIBH CTs were rigidly 
registered on the first one, matched either on the tumour or 
the carina. The intra- and inter-observer uncertainty of the 
manual registration process was evaluated as well.  
Potential impact of DIBH on the CTV-PTV margins was 
investigated. 
Results: Lung volume increased in DIBH by 64% (median; 
range 35-108%; p < 0.001; paired t-test) compared to free 
breathing. Variations in lung volume while the patient was in 
DIBH were small, with intra-fractional median 1.1% (range 
0.1-5.6%) and inter-fractional median 2.1% (0.3-4.6%). There 
was no intra-fractional trend in lung volume changes, but 
inter-fractionally there was a slight trend towards increased 
lung volume on day 31 (p<0.004), probably due to tumour 
shrinkage in some of the patients. 
Intra- and inter-observer uncertainties in tumour and carina 
image registration were < 0.6 mm. 
Intra-fractional uncertainty in 3D tumour position was 1.7 ± 
1.4 mm (mean ± SD) and below 2 mm for 70% of cases. No 
trend was observed throughout the RT course. Intra-
fractional differential motion between the primary tumour 
and the mediastinal lymph nodes was 0.0 ± 1.1 mm, 
indicating good geometrical agreement. 
DIBH facilitated a minor margin reduction compared to RT in 
free breathing, by 1-3 mm, depending on extent of tumour 
motion in free breathing. 
More details are presented in the table. 
 
 
Conclusions: DIBH is a feasible approach for locally advanced 
NSCLC. The intra-fractional reproducibility of the tumour 
position remained high during the whole RT course, provided 
daily image guidance with tumour match is applied. 
Additional benefit of DIBH was absence of differential motion 
between the primary tumour and the mediastinal lymph 
nodes.  
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Purpose/Objective: To systematically evaluate the 
effectiveness of re-scanning for the Varian ProBeam PBS 
proton therapy system in the context of liver tumour 
treatments 
Materials and Methods: 3 deformable motions (mean 
amplitude of 8/15/20mm, corresponding to Motion A/B/C in 
figure 1) were extracted from a 4DMRI library (Siebenthal et 
al 2007, Phys. Med. Biol. 52; Boye et al 2013, Med. Phys. 40) 
and respectively applied to 3 different liver patient 
geometries with varying tumour volumes (100/200/400ccm). 
Reference 3D plans were first calculated to patient specific 
ITV's (2GyRBE) using spot spacing of 4/8mm for both 1- and 3-
field plans. 4D dose calculations were then performed for 
both regular and irregular motions, each with 4 different 
starting phases. For each scenario, 1-19 times adaptive-
scaled, layered and volumetric rescanning were simulated 
using the beam profiles, scanning dynamics and beam 
currents of the Varian ProBeam system. In addition, 4 energy 
switching times (700/500/200/100ms) were modelled. All 4D 
dose distributions were assessed by means of the D5-D95 
metric in the CTV. 
Results: In total, more than 100 thousand 4D calculations 
have been performed, covering 10 different patient, motion 
and dose delivery variables. Regardless of patient geometry 
and motion regularity, the 3-field plans can achieve D5-D95 
values within 6.5% of the static values without any re-
